The Forward P/E of Kiniksa Pharmaceuticals International PLC (KNSA) is 41.50.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.